Skip to main content

and
  1. Article

    Open Access

    Nintedanib administration after the onset of acute exacerbation of interstitial lung disease in the real world

    Nintedanib reduces the decline in forced vital capacity and extends the time to the first acute exacerbation of interstitial lung disease (AE-ILD). However, the effect of additional nintedanib administration a...

    Motoyasu Kato, Shinichi Sasaki, Wataru Mori, Makiko Kohmaru in Scientific Reports (2023)

  2. Article

    Open Access

    The synergetic effect of sitafloxacin–arbekacin combination in the Mycobacterium abscessus species

    Mycobacterium abscessus species (MABS) is the most commonly isolated rapidly growing mycobacteria (RGM) and is one of the most antibiotic-resistant RGM with rapid progression, therefore, treatment of MABS is stil...

    Junko Watanabe, Hiroaki Ihara, Satomi Takei, Ayako Nakamura in Scientific Reports (2023)

  3. Article

    Open Access

    High lymphocyte population-related predictive factors for a long-term response in non-small cell lung cancer patients treated with pemetrexed: a retrospective observational study

    Regimens combining pemetrexed (PEM) and immune checkpoint inhibitors (ICIs) targeting programmed cell death-1 (PD-1) or programmed death-ligand 1 (PD-L1) are widely used for the treatment of advanced non-squam...

    Issei Sumiyoshi, Takahiro Okabe, Shinsaku Togo in Journal of Translational Medicine (2021)

  4. Article

    Open Access

    The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex

    Nontuberculous mycobacteria (NTM) are ubiquitous organisms and the incidence of NTM infections has been increasing in recent years. Mycobacteroides abscessus (M. abscessus) is one of the most antimicrobial-resist...

    Satomi Takei, Hiroaki Ihara, Shinsaku Togo, Ayako Nakamura in BMC Microbiology (2020)

  5. Article

    Open Access

    Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1

    Pirfenidone, an antifibrotic agent used for the treatment of idiopathic pulmonary fibrosis (IPF), functions by inhibiting myofibroblast differentiation, which is involved in transforming growth factor (TGF)-β1...

    ** **, Shinsaku Togo, Kotaro Kadoya, Miniwan Tulafu, Yukiko Namba in Respiratory Research (2019)

  6. Article

    Open Access

    Cancer cell migration on elongate protrusions of fibroblasts in collagen matrix

    Cancer-associated fibroblasts (CAFs) play critical roles in the tumor progression. However, it remains unclear how cancer cells migrate in the three-dimensional (3D) matrix of cancer tissues and how CAFs suppo...

    Kaoru Miyazaki, Jun Oyanagi, Daisuke Hoshino, Shinsaku Togo in Scientific Reports (2019)

  7. Article

    Open Access

    Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study

    Liquid biopsy approaches, such as measuring circulating tumour cells (CTCs), have recently been introduced in several clinical studies. However, the development of CTCs as a predictive marker for treatment eff...

    Yoshiya Horimoto, Emi Tokuda, Fumi Murakami in Journal of Translational Medicine (2018)

  8. Article

    Open Access

    Combination of glycopyrronium and indacaterol inhibits carbachol-induced ERK5 signal in fibrotic processes

    Airway fibrosis is one of the pathological features of chronic obstructive pulmonary disease (COPD), and recent studies revealed that acetylcholine plays an important role in the development of airway remodeli...

    Yukiko Namba, Shinsaku Togo, Miniwan Tulafu, Kotaro Kadoya in Respiratory Research (2017)

  9. Article

    Open Access

    Lung adenocarcinoma expressing receptor for advanced glycation end-products with primary systemic AL amyloidosis: a case report and literature review

    Receptor for advanced glycation end-products (RAGE), a receptor for amyloids, is constitutively expressed in lungs and generally observed to be downregulated in lung cancer tissues. However, increasing levels ...

    Shouichi Okamoto, Shinsaku Togo, Ichiro Nagata, Kazue Shimizu in BMC Cancer (2017)

  10. No Access

    Chapter

    Association of COPD and Lung Cancer: How Does COPD Management Change the Outcome of Treatment of Lung Cancer?

    Chronic obstructive pulmonary disease (COPD) and lung cancer are caused by cigarette smoking, and there is increasing evidence linking the two diseases beyond a common etiology. COPD is widely considered to be...

    Shinsaku Togo, Yukiko Namba, Kazuhisa Takahashi in Chronic Obstructive Pulmonary Disease (2017)

  11. Article

    Open Access

    Differentiation of embryonic stem cells into fibroblast-like cells in three-dimensional type I collagen gel cultures

    Fibroblasts are heterogeneous mesenchymal cells that play important roles in the production and maintenance of extracellular matrix. Although their heterogeneity is recognized, progenitor progeny relationships...

    Shinsaku Togo, Tadashi Sato in In Vitro Cellular & Developmental Biology … (2011)

  12. Article

    Open Access

    NF-kappaB mediates the survival of human bronchial epithelial cells exposed to cigarette smoke extract

    We have previously reported that low concentrations of cigarette smoke extract induce DNA damage without leading to apoptosis or necrosis in human bronchial epithelial cells (HBECs), and that IL-6/STAT3 signal...

    **angde Liu, Shinsaku Togo, Mona Al-Mugotir, Huijung Kim in Respiratory Research (2008)